Cost-Effectiveness Analysis 2.0.
Publication
, Journal Article
Neumann, PJ; Sanders, GD
Published in: N Engl J Med
January 19, 2017
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
N Engl J Med
DOI
EISSN
1533-4406
Publication Date
January 19, 2017
Volume
376
Issue
3
Start / End Page
203 / 205
Location
United States
Related Subject Headings
- United States
- Quality-Adjusted Life Years
- Humans
- Health Care Rationing
- Health Care Costs
- Guidelines as Topic
- General & Internal Medicine
- Cost-Benefit Analysis
- 42 Health sciences
- 32 Biomedical and clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Neumann, P. J., & Sanders, G. D. (2017). Cost-Effectiveness Analysis 2.0. N Engl J Med, 376(3), 203–205. https://doi.org/10.1056/NEJMp1612619
Neumann, Peter J., and Gillian D. Sanders. “Cost-Effectiveness Analysis 2.0.” N Engl J Med 376, no. 3 (January 19, 2017): 203–5. https://doi.org/10.1056/NEJMp1612619.
Neumann PJ, Sanders GD. Cost-Effectiveness Analysis 2.0. N Engl J Med. 2017 Jan 19;376(3):203–5.
Neumann, Peter J., and Gillian D. Sanders. “Cost-Effectiveness Analysis 2.0.” N Engl J Med, vol. 376, no. 3, Jan. 2017, pp. 203–05. Pubmed, doi:10.1056/NEJMp1612619.
Neumann PJ, Sanders GD. Cost-Effectiveness Analysis 2.0. N Engl J Med. 2017 Jan 19;376(3):203–205.
Published In
N Engl J Med
DOI
EISSN
1533-4406
Publication Date
January 19, 2017
Volume
376
Issue
3
Start / End Page
203 / 205
Location
United States
Related Subject Headings
- United States
- Quality-Adjusted Life Years
- Humans
- Health Care Rationing
- Health Care Costs
- Guidelines as Topic
- General & Internal Medicine
- Cost-Benefit Analysis
- 42 Health sciences
- 32 Biomedical and clinical sciences